1 |
coxsackievirus B3
(980 times)
|
Virology (272 times)
|
VMC (62 times) IL (36 times) CAR (30 times)
|
1978 Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.
|
2 |
Coxsackievirus group B type 3
(19 times)
|
Allergy and Immunology (9 times)
|
PFU (3 times) CTL (2 times) ACTL (1 time)
|
1984 Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
|
3 |
coxsackie B3 virus
(12 times)
|
Complementary Therapies (2 times)
|
AM (2 times) FM (2 times) ABTS (1 time)
|
1995 The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication.
|
4 |
CVB type 3
(11 times)
|
Virology (5 times)
|
CVB (8 times) CAR (2 times) circRNAs (1 time)
|
2004 Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
|
5 |
anti-coxsackievirus B3
(2 times)
|
Virology (1 time)
|
SAR (1 time) shRNA (1 time) SI (1 time)
|
2007 Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
|
6 |
coxsackie B virus 3
(1 time)
|
Virology (1 time)
|
CVA16 (1 time) CVs (1 time) EV71 (1 time)
|
2016 2C Proteins of Enteroviruses Suppress IKKbeta Phosphorylation by Recruiting Protein Phosphatase 1.
|
7 |
Coxsackie group B3 virus
(1 time)
|
Cardiology (1 time)
|
COX (1 time) DEX (1 time)
|
2013 Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis.
|
8 |
coxsackie-B3 virus strain Nancy
(1 time)
|
Virology (1 time)
|
CAR (1 time) HUVEC (1 time)
|
2010 Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.
|
9 |
Coxsackievirus B3 virus strain
(1 time)
|
Virology (1 time)
|
IFN (1 time) VSV (1 time)
|
2005 [Effect of Chinese herbal medicine Xin-kang oral liquid on interferon-induction and its antiviral activity in coxsackievirus B3 infected mice].
|
10 |
coxsackievirus group B3 virus
(1 time)
|
Cardiology (1 time)
|
---
|
2017 IL-33 enhances macrophage M2 polarization and protects mice from CVB3-induced viral myocarditis.
|
11 |
Coxsackievirus group B3 virus infection
(1 time)
|
Allergy and Immunology (1 time)
|
VMC (1 time)
|
2019 Calpain regulates CVB3 induced viral myocarditis by promoting autophagic flux upon infection.
|
12 |
CV strain B3
(1 time)
|
Biochemistry (1 time)
|
CoV (1 time) CV (1 time) SARS (1 time)
|
2009 Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
|
13 |
CVB3 group
(1 time)
|
Cardiology (1 time)
|
alpha-SMA (1 time) CCK-8 (1 time) CMVECs (1 time)
|
2017 Ginsenoside-Rb3 inhibits endothelial-mesenchymal transition of cardiac microvascular endothelial cells.
|
14 |
CVB3 persistence in HL-1
(1 time)
|
Virology (1 time)
|
CAR (1 time)
|
2011 Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
|
15 |
CVB3-infected murine cardiac myocyte cell line, HL-1
(1 time)
|
Virology (1 time)
|
CAR (1 time)
|
2011 Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
|
16 |
CVB3rec
(1 time)
|
Virology (1 time)
|
CVB3wt (1 time) IL-10 (1 time)
|
2001 Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
|